- Home
- AXSM vs OLED Comparison
AXSM vs OLED Comparison
Compare AXSM & OLED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | OLED |
|---|---|---|
| Founded | 2012 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 7.1B |
| IPO Year | 2015 | 1992 |
Fundamental Metrics
Financial Performance| Metric | AXSM | OLED |
|---|---|---|
| Price | $149.29 | $122.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 6 |
| Target Price | $176.00 | ★ $181.33 |
| AVG Volume (30 Days) | 551.7K | ★ 682.6K |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.48% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.64 |
| Revenue | $561,263,000.00 | ★ $639,977,000.00 |
| Revenue This Year | $66.20 | $2.50 |
| Revenue Next Year | $57.56 | $10.90 |
| P/E Ratio | ★ N/A | $26.14 |
| Revenue Growth | ★ 65.83 | N/A |
| 52 Week Low | $75.56 | $103.70 |
| 52 Week High | $152.94 | $165.00 |
Technical Indicators
Market Signals| Indicator | AXSM | OLED |
|---|---|---|
| Relative Strength Index (RSI) | 60.77 | 47.06 |
| Support Level | $141.69 | $120.16 |
| Resistance Level | $151.63 | $122.61 |
| Average True Range (ATR) | 4.61 | 3.26 |
| MACD | -0.59 | 1.79 |
| Stochastic Oscillator | 67.13 | 90.76 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About OLED Universal Display Corporation
Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.